Detalles de la búsqueda
1.
Social value of a set of proposals for the ideal approach of multiple sclerosis within the Spanish National Health System: a social return on investment study.
BMC Health Serv Res
; 20(1): 84, 2020 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32019531
2.
Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment.
Mediators Inflamm
; 2019: 8147803, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31346315
3.
Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis.
Front Neurol
; 15: 1371644, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38708001
4.
The evolution of multiple sclerosis in Spain over the last decade from the patient's perspective.
Mult Scler Relat Disord
; 57: 103355, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158463
5.
Patient experience and self-perceived biopsychosocial burden of people living with multiple sclerosis: An epidemiological survey (BPS-MuScle study) in Spain.
Mult Scler Relat Disord
; 56: 103186, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34455136
6.
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients.
CNS Neurosci Ther
; 24(12): 1175-1184, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29656444
Resultados
1 -
6
de 6
1
Próxima >
>>